BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 7691098)

  • 41. Insulin-like growth factor binding protein-4, -5 and -6 mRNAs in the human fetus: localization to sites of growth and differentiation?
    Delhanty PJ; Hill DJ; Shimasaki S; Han VK
    Growth Regul; 1993 Mar; 3(1):8-11. PubMed ID: 7683540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin-like growth factor binding protein-4 inhibits both basal and IGF-mediated chick pelvic cartilage growth in vitro.
    Schiltz PM; Mohan S; Baylink DJ
    J Bone Miner Res; 1993 Apr; 8(4):391-6. PubMed ID: 7682750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1.
    Jyung RW; Mustoe JA; Busby WH; Clemmons DR
    Surgery; 1994 Feb; 115(2):233-9. PubMed ID: 7508640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells.
    Andress DL; Loop SM; Zapf J; Kiefer MC
    Biochem Biophys Res Commun; 1993 Aug; 195(1):25-30. PubMed ID: 7689835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.
    Kricker JA; Towne CL; Firth SM; Herington AC; Upton Z
    Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IGF binding proteins: regulation of cellular actions.
    Clemmons DR
    Growth Regul; 1992 Jun; 2(2):80-7. PubMed ID: 1283101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Localization of the epitope of a monoclonal antibody against human insulin-like growth factor binding protein-1, functionally interfering with insulin-like growth factor binding.
    Schuller AG; Lindenbergh-Kortleve DJ; de Boer WI; Zwarthoff EC; Drop SL
    Growth Regul; 1993 Mar; 3(1):32-4. PubMed ID: 7683523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of insulin-like growth factor and binding protein genes during nephrogenesis.
    Matsell DG; Delhanty PJ; Stepaniuk O; Goodyear C; Han VK
    Kidney Int; 1994 Oct; 46(4):1031-42. PubMed ID: 7532247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Somatomedins].
    Chevenne D
    Ann Biol Clin (Paris); 1991; 49(2):69-91. PubMed ID: 1648311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins.
    McCusker RH; Busby WH; Dehoff MH; Camacho-Hubner C; Clemmons DR
    Endocrinology; 1991 Aug; 129(2):939-49. PubMed ID: 1713163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin-like growth factor binding proteins in bone cell regulation.
    Mohan S
    Growth Regul; 1993 Mar; 3(1):67-70. PubMed ID: 7683536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D.
    Claussen M; Kübler B; Wendland M; Neifer K; Schmidt B; Zapf J; Braulke T
    Endocrinology; 1997 Sep; 138(9):3797-803. PubMed ID: 9275067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new method for the purification of bioactive insulin-like growth factor-binding protein-3.
    Pircher H; Matscheski A; Laich A; Hermann M; Moser B; Viertler HP; Micutkova L; Lindner H; Sarg B; Zwerschke W; Jansen-Dürr P
    Protein Expr Purif; 2010 Jun; 71(2):160-7. PubMed ID: 20153430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitory effects of insulin-like growth factor (IGF)-binding proteins-1 and -3 on IGF-activated glucose consumption in mouse BALB/c 3T3 fibroblasts.
    Okajima T; Iwashita M; Takeda Y; Sakamoto S; Tanabe T; Yasuda T; Rosenfeld RG
    J Endocrinol; 1993 Mar; 136(3):457-70. PubMed ID: 7682592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex.
    Bang P; Brismar K; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 May; 78(5):1119-27. PubMed ID: 7513716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II.
    Gockerman A; Prevette T; Jones JI; Clemmons DR
    Endocrinology; 1995 Oct; 136(10):4168-73. PubMed ID: 7545099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin-like growth factor-I (IGF-I) enhanced proteolysis of IGF-binding protein-4 in conditioned medium from primary cultures of human decidua: independence from IGF receptor binding.
    Myers SE; Cheung PT; Handwerger S; Chernausek SD
    Endocrinology; 1993 Oct; 133(4):1525-31. PubMed ID: 7691578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth factors and the control of folliculogenesis.
    Monget P; Monniaux D
    J Reprod Fertil Suppl; 1995; 49():321-33. PubMed ID: 7542711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.
    Sitar T; Popowicz GM; Siwanowicz I; Huber R; Holak TA
    Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13028-33. PubMed ID: 16924115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estrogen and insulin modulation of intracellular insulin-like growth factor binding proteins in human breast cancer cells: possible involvement in lysosomal hydrolases oversecretion.
    Dubois V; Couissi D; Schonne E; Schneider YJ; Remacle C; Trouet A
    Biochem Biophys Res Commun; 1993 Apr; 192(1):295-301. PubMed ID: 7682810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.